Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

155386-25-7N-Nitroso Vancomycin

● Auf Lager

Katalog-Nr.::	VE0011293
CAS-Nr.::	155386-25-7
Summenformel::	C66H74Cl2N10O25
Molare Masse::	1478.3 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 155386-25-7

FDA Potency Category 4 NDSRI

1500 ng/day is the U.S. FDA’s current Acceptable Intake (AI) limit for N-nitroso-vancomycin (NDSRI). Refer to the FDA nitrosamine page for the latest guidance.

Parent drug

Vancomycin

IUPAC-Name

Vancomycin Nitroso Impurity

Pharmakopöe-Synonyme

N/A

Other Synonyms

Vancomycin Nitroso Impurity

SMILES

N[C@@]1(C)C[C@@](O[C@H]2[C@H](OC3=C(OC4=C(Cl)C=C([C@H]([C@](C(N[C@@](C(O)=O)([H])C5=C6C(O)=CC(O)=C5)=O)([H])N7)O)C=C4)C=C8C=C3OC9=CC=C([C@H]([C@@H](NC([C@@H](CC(C)C)N(C)N=O)=O)C(N[C@H](C(N[C@@]8([H])C(N[C@](C7=O)([H])C=CC6=C(O)C=C)=O)=O)CC(N)=O)=O)O)C=C9Cl)O[C@H](CO)[C@@H](O)[C@@H]2O)([H])O[C@@H](C)[C@H]1O

InChI

InChI=1S/C66H74Cl2N10O25/c1-23(2)12-35(78(5)77-97)59(90)75-49-51(84)26-7-10-38(32(67)14-26)99-40-16-28-17-41(55(40)103-65-56(54(87)53(86)42(22-79)101-65)102-44-21-66(4,70)57(88)24(3)98-44)100-39-11-8-27(15-33(39)68)52(85)50-63(94)74-48(64(95)96)31-18-29(80)19-37(82)45(31)30-13-25(6-9-36(30)81)46(60(91)76-50)73-61(92)47(28)72-58(89)34(20-43(69)83)71-62(49)93/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,79-82,84-88H,12,20-22,70H2,1-5H3,(H2,69,83)(H,71,93)(H,72,89)(H,73,92)(H,74,94)(H,75,90)(H,76,91)(H,95,96)/t24-,34-,35+,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-/m0/s1

Shipping Condition

Ambient Temperature

Beschreibung

N-Nitroso Vancomycin Impurity is an N-nitroso derivative of the secondary amine present in Vancomycin | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Vancomycin production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.